Company intelligence / Profile preview

Invivotek

Hamilton, New Jersey, United Statesinvivotek.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Invivotek does not develop its own clinical candidates but provides preclinical in vivo pharmacology services to support drug discovery and development for clients. No proprietary clinical results.

Therapeutic areas: OncologyMetabolic DisordersRare DiseasesImmunologyNeurology
Modalities: Small moleculeBiologicCell therapyAntibodyGene-modified rodent models
Industry: Drug Discovery Services

Partnerships

Not specifically listed; as a CRO they partner with biotech/pharma clients broadly.

Beyond the preview

Go deeper on Invivotek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invivotek.

Explore the full profile